These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1835275)

  • 1. GnRH agonists: gonadorelin, leuprolide and nafarelin.
    Pace JN; Miller JL; Rose LI
    Am Fam Physician; 1991 Nov; 44(5):1777-82. PubMed ID: 1835275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic uses of gonadotropin-releasing hormone analogs.
    Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
    Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gonadotropin releasing hormone (GnRH) antagonists--a new provocation in gynecology].
    Vladimirov Ia
    Akush Ginekol (Sofiia); 2002; 41(3):36-42. PubMed ID: 12145978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinician's guide to the use of gonadotropin-releasing hormone analogues in women.
    Moghissi KS
    Medscape Womens Health; 2000 Jan; 5(1):5. PubMed ID: 10792849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gonadotropin-releasing hormone agonists, nafarelin, buserelin, and leuprolide, on experimentally induced endometriosis in the rat.
    Mizutani T; Sakata M; Terakawa N
    Int J Fertil Menopausal Stud; 1995; 40(2):106-11. PubMed ID: 7599657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone agonists. Current uses for these increasingly important drugs.
    Winkel CA
    Postgrad Med; 1994 May; 95(6):111-8. PubMed ID: 8170869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone and its receptor in normal and malignant cells.
    Harrison GS; Wierman ME; Nett TM; Glode LM
    Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin-releasing hormone and its clinical applications.
    Loucopoulos A; Ferin M
    Obstet Gynecol Annu; 1984; 13():275-88. PubMed ID: 6326010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety and mood disorders associated with gonadotropin-releasing hormone agonist therapy.
    Warnock JK; Bundren JC
    Psychopharmacol Bull; 1997; 33(2):311-6. PubMed ID: 9230649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of synthetic agonist analogue of gonadotropin-releasing hormone (leuprolide) on testicular androgen production in patients with carcinoma of prostate.
    Santen RJ; Warner B
    Urology; 1985 Feb; 25(2 Suppl):53-7. PubMed ID: 3918377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gonadotropin-releasing hormone analogs].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 May; 18(107):585-9. PubMed ID: 16161962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GnRH analogues in the treatment of endometriosis.
    Erickson LD; Ory SJ
    Obstet Gynecol Clin North Am; 1989 Mar; 16(1):123-45. PubMed ID: 2526312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin--a clinical research center study.
    Rosenfield RL; Perovic N; Ehrmann DA; Barnes RB
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3408-11. PubMed ID: 8784105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists.
    Bedaiwy MA; Mousa NA; Casper RF
    Fertil Steril; 2009 Apr; 91(4 Suppl):1574-7. PubMed ID: 18973892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leuprolide acetate: a drug of diverse clinical applications.
    Wilson AC; Meethal SV; Bowen RL; Atwood CS
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1851-63. PubMed ID: 17970643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analogs of gonadoliberin. Value in physiology and therapeutics].
    Charbonnel B
    Presse Med; 1994 Apr 30-May 7; 23(17):805-11. PubMed ID: 8078839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
    Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
    Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [History of clinical studies on hypothalamic hormone analogs in Mexico].
    Schally AV; González Bárcena D
    Gac Med Mex; 2006; 142(4):315-25. PubMed ID: 17022307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats.
    Okada H; Heya T; Ogawa Y; Shimamoto T
    J Pharmacol Exp Ther; 1988 Feb; 244(2):744-50. PubMed ID: 3126294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sterile abscess formation in response to two separate branded long-acting gonadotropin-releasing hormone agonists.
    Miller BS; Shukla AR
    Clin Ther; 2010 Sep; 32(10):1749-51. PubMed ID: 21194598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.